Distinct bile salt hydrolase substrate preferences dictate C. difficile pathogenesis

Bile acids (BAs) mediate the crosstalk between human and microbial cells and influence intestinal diseases including Clostridioides difficile infection (CDI). While bile salt hydrolases (BSHs) shape the BA pool by deconjugating conjugated BAs, the basis for their substrate preferences and impact on C. difficile remain elusive. Here, we survey the diversity of Lactobacillus BSHs and unravel the structural basis of their substrate preference. We show that leveraging BSH activity and specificity is an effective strategy to prevent C. difficile growth in clinically relevant CDI models. A range of non-canonical conjugated BAs is also identified, comprising unique BSH substrates that also inhibit C. difficile spore germination. These findings establish BSHs as intestinal enzymes essential to BA homeostasis and colonization resistance against C. difficile. One sentence summary Bile salt hydrolase activity inhibits C. difficile by shaping the conventional and non-canonical conjugated bile acid pools

[1]  R. Barrangou,et al.  Lactobacillus bile salt hydrolase substrate specificity governs bacterial fitness and host colonization , 2021, Proceedings of the National Academy of Sciences.

[2]  D. A. Harris,et al.  Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects , 2020, Nature Chemical Biology.

[3]  Y. Hahn,et al.  Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health , 2020, Gut microbes.

[4]  Julie C. Lumeng,et al.  Global chemical effects of the microbiome include new bile-acid conjugations , 2020, Nature.

[5]  H. Sokol,et al.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[6]  I. Tikhonova,et al.  The complex structure of bile salt hydrolase from Lactobacillus salivarius reveals the structural basis of substrate specificity , 2019, Scientific Reports.

[7]  Simon C. Potter,et al.  The EMBL-EBI search and sequence analysis tools APIs in 2019 , 2019, Nucleic Acids Res..

[8]  R. Barrangou,et al.  Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract , 2019, PLoS pathogens.

[9]  Thomas B. Clarke,et al.  Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection , 2019, Gut.

[10]  T. Weir,et al.  The gut microbiota at the intersection of diet and human health , 2018, Science.

[11]  Amir I. Mina,et al.  A selective gut bacterial bile salt hydrolase alters host metabolism , 2018, eLife.

[12]  Casey M. Theriot,et al.  Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells , 2018, Science.

[13]  R. Thanissery,et al.  Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids. , 2017, Anaerobe.

[14]  H. Gaskins,et al.  Taurocholic acid metabolism by gut microbes and colon cancer , 2016, Gut microbes.

[15]  P. Hylemon,et al.  Consequences of bile salt biotransformations by intestinal bacteria , 2016, Gut microbes.

[16]  C. Hill,et al.  Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk , 2014, Gut microbes.

[17]  C. Hill,et al.  Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut , 2014, Proceedings of the National Academy of Sciences.

[18]  Bo Li,et al.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection , 2014, Nature Communications.

[19]  S. Prakash,et al.  Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications , 2013, Expert opinion on biological therapy.

[20]  Hsin-Chieh Yeh,et al.  Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. , 2013, JAMA internal medicine.

[21]  Tetsuya Hayashi,et al.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. , 2011, Gastroenterology.

[22]  A. Sonenshein,et al.  Chenodeoxycholate Is an Inhibitor of Clostridium difficile Spore Germination , 2008, Journal of bacteriology.

[23]  A. Sonenshein,et al.  Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores , 2008, Journal of bacteriology.